Received February 09, 2023
Accepted August 17, 2023

Objective- To follow the impact of the SARS-COV-2 pandemic on the practice of assisted reproductive technology in centers reporting to the Latin American Registry during 2020. Material and methods- An internally validated online survey designed on the Survey Monkey platform, maximum of 20 closed questions was sent via e-mail or WhatsApp to the clinical director of each center reporting to the Latin American Registry of Assisted Reproduction between July and December 2020. Results- The number of centers responding to the survey varied during the six months. The relative contribution of Brazil to all responses was 41.4% to 45%, followed by México (16.2% to 23.8%), Argentina (8.1% to 12.6%), Colombia (7.1% to 8.2%), Chile (3.6% to 6.1%) and Perú (4.0% to 4.9%). Most centers reported stopping activities before July (81%). Covid-19 related symptoms was a criterion on its own to postpone ovarian stimulation (80.1% to 87.7% of centers). Although in July only 76 of 166 centers (45.8%) performed embryo transfers, by October 104 of 109 centers (95.4%) performed them. In survey 6 (December) 78 of 79 center (98.7%) that had initially closed had already reopened although 62.3% (61 of 98 centers) still performed 80% or less of their usual number of ART cycles. Conclusions-Most centers modified their clinical practice and applied specific protocols to screen their staff and patients. Suspicion of Covid-19 delayed treatments. Despite a peak of the pandemic, by December most centers were performing all ART treatments although the number of cycles remained low compared to the pre-pandemic practice